Background/Aims: Interferon regulatory factor 1 (IRF-1) has been shown to function as a transcriptional activator or repressor of a variety of target genes. However, its upstream, noncoding RNA-related regulatory capacity remains unknown. In this study, we focus on the miRNA-associated single nucleotide polymorphisms (SNPs) in the 3′untranslated region (UTR) of IRF-1 to further investigate the functional relationship and potential diagnostic value of the SNPs and miRNAs among Chinese gastric cancer (GC) patients. Methods: We performed a case-control study with 819 GC patients and 756 cancer-free controls. Genotyping by realtime PCR assay, cell transfection, and the dual luciferase reporter assay were used in our study, and the 5-year overall survival rate and relapse-free survival rate in different groups were investigated. Results: We found that patients suffering from Helicobacter pylori (Hp) infection were the susceptible population compared to controls. SNP rs56288038 (C/G) in IRF-1 3′UTR was involved in the occurrence of GC by acting as a tumor promoter factor. SNP rs56288038 (C/G) could be up-regulated by miR-502-5p, which caused a down-regulation of IRF-1 in cell lines and decreased apoptosis induced by IFN-γ. Carrying the G genotype was related to significantly low expression of IRF-1 and Hp infection, poor differentiation, big tumor size, invasion depth, as well as the high probability of metastasis, and moreover, the C/G SNP was associated with shorter survival of GC patients with five years of follow-up study. Conclusions: our findings have shown that the SNP rs56288038 (C/G) in IRF-1 3′UTR acted as a promotion factor in GC development through enhancing the regulatory role of miR-502-5p in IRF-1 expression.
Introduction
Gastric cancer (GC) is the fifth-leading cancer worldwide, accounting for approximately 9% of total deaths from cancer annually. In 2012, it was reported that GC occurred in 950,000 people and caused 723,000 deaths [1] . East Asia and Eastern Europe were the two regions with the highest GC incidence in the world, and the incidence among males was approximately twice that in females. Helicobacter pylori (Hp) infection was the most common cause of GC, causing chronic inflammation in the stomach, damage to the gastric mucus, and corresponding immune responses, leading to stomach problems. The current diagnostic system has been proved to be relatively poor in early-stage diagnosis of GC, and accumulating evidence is demonstrating the great potential of microRNAs (miRNAs) as useful biomarkers in GC diagnosis [2] [3] [4] .
Interferon (IFN) regulatory factor-1 (IRF-1) was isolated by its affinity to specific DNA sequences in the IFN-beta promoter that mediates virus responsiveness. It was the first factor identified in the IRF family and was most extensively characterized at the molecular level. Also, its physiologic role in host defense against pathogens, tumor prevention, and development of the immune system was investigated in detail [5] . Early in 1998, Nozawa et al. discovered an inactivating point mutation within the IFR-1 gene which markedly reduced the transcriptional activity and significantly increased the development of human GC [6] . And Gao et al. reported its therapeutic potential in that overexpression of IRF-1 can increase the chemosensitivity of GC cells to 5-fluorouracil [7] . In addition, the human mucosal inflammatory response to Hp antigens, such as OipA and the cag PAI, were largely dependent on the transcriptional factors including IRF-1, AP-1, STAT1 etc. [8] . Therefore, IRF1 is a key factor in development human gastric cancer.
miRNAs are a class of small, noncoding, approximately 22-nucleotide-long RNAs, which may function as post-transcriptional regulators of gene expression by targeting their 3′ untranslated region (UTR). Many miRNAs have been reported to be associated with enhanced expression of IRF-1 in different cancers, including mIR-342 [9] and miR-31 [10] . However, the existence of functional SNPs was identified in many studies, and an SNP in the 3′UTR region was often related to "Loss" and "Gain" functions of certain genes [11] [12] [13] .
In this study, we focused on the 3′UTR region of IRF-1 to investigate the reason for down-regulation of IRF-1 in human gastric cancer. Using bioinformatics software (http:// www.bioguo.org/miRNASNP/), we obtained all the SNPs which could regulate by miRNAs. Using the bioinformatics prediction, we found the rs56288038 (C/G) in IRF-1 3′UTR were two SNPs which might potentially be regulated by miR-502-5p; we further investigated the allele distribution in a case-control study.
Materials and Methods
Study subjects A total of 819 GC cases and sex plus age-matched 765 healthy controls obtained from the 1 st and 2 nd affiliated hospital to Soochow University, were included in this study. Patients were enrolled between February 2010 and January 2015. All cases are incident ones during enrollment of the current case-control study. The diagnosis of all patients was histological confirmed. A face-to-face questionnaire was administered to collect demographic data and environmental exposure information, including alcohol use and cigarette consumption status as well as family cancer history. All participants have provided their written informed consents to participate in this study. This study was approved by the Institutional Review Board of the 1 st and 2 nd affiliated hospital of Soochow University.
Genotype
The polymorphism was genotyped through the PCR-restriction fragment length polymorphism (RFLP) method as strictly according to the SNP detection kit (Thermo Fisher, CA). The PCR reactions were carried out in a total volume of 5 μL containing TaqMan Universal Master Mix, 80X SNP Genotyping AssayMix, DNase-free water and 10 ng genomic DNA. The PCR conditions were 2 min at 50°C, 10 min at 95°C, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min by the 384-well ABI 7900HT Real-Time PCR System. A 10% random sample was reciprocally examined by different persons, and the reproducibility was 100%.
Real-time PCR assay
Real-time polymerase chain reaction (RT-PCR) was performed to determine whether the mutation changed the expression level of IRF-1. The primers used for amplification were forward primer: ATGCCCATCACTCGGATGC, and reverse primer: CCCTGCTTTGTATCGGCCTG for IRF-1 and forward primer: TGTGGGCATCAATGGATTTGG, reverse primer: ACACCATGTATTCCGGGTCAAT for GAPDH. The amplification conditions were 95°C for 10 minutes, followed by 40cycles of 95°C for 30 seconds, 55°C for 40 seconds, and 72°C for 30 seconds, and finally 4°C for 30 minutes for cooling by the 384-well ABI 7900HT Real-Time PCR System.
Cell lines and cell culture
GC cell lines MKN-45 and SGC-7901 were purchased from the ATCC. All cells were cultured in Dulbecco's Minimum Essential Medium (DMEM) purchased from Gibco (CA, USA) supplemented with 10% fetal bovine serum (Thermo Fisher, CA) and grown in humidified 5% CO2 at 37˚C. MiR-502-5p and miR1225a mimics and normal control were obtained from Genepharma (Shanghai, China).The transfection was conducted by using Lipofectamine 2000 (Thermo Fisher, CA).
Immunohistochemistry (IHC)
Sections were de-paraffinized and followed by rehydration steps through a graded ethanol series and distilled water, and then were treated with 3% H 2 O 2 in methanol for 30 min to block the endogenous peroxidase activity. The sections were rinsed in phosphate-buffered saline (PBS) twice, 5 min each time and incubated with 10% normal goat serum for 30 min to block non-specific antibody binding. After washing, the samples were incubated with primary anti-rabbit antibody IRF-1 (ab1 86448) purchased from Abcam (Cambridge, UK) at 4°C overnight, and then washed with PBS for three times and then incubated with secondary antibodies. After that, the sections were stained with DAB according to manufacturer's protocols and mounted and photographed using a digitalized microscope camera (Nikon, Tokyo, Japan).
Prediction of miRNAs binding to the SNP
Based on our bioinformatics analysis by using the bioinformatics software (http://www.bioguo.org/ miRNASNP/) to predict the related SNPs in the 3'UTR of IRF-1, which could interact with miRNAs.
Construction of luciferase-based reporter plasmids
A full-length fragment of the 3'UTR containing rs56288038 (C/G) (Wild type/mutant) were amplified. The PCR production was cloned into the pGL3-promoter luciferase-based plasmid (Promega) at the cloning site between KpnI and XhoI. Moreover, the IRF-1 expression plasmid was modified based on pGL-3 IRF-1 3'UTR vector, replacing luciferase by IRF-1. The amplified fragment was verified by DNA sequencing.
Dual-luciferase reporter assay
For luciferase activity analysis, MKN-45 and SGC-7901 cells were cotransfected with 100ng of luciferase reporter constructs 5 ng of the β-gal control plasmid and 10 pmol of miRNAs with 1 µl Lipofectamine 2000 according to the manufacturer's instructions (Thermo Fisher, USA). After incubation for 48 h, we carried out the luciferase assay using the luciferase reporter assay system (Promega, Madison, WI) according to the manufacturer's protocol. Measurements of luminescence and absorbance of β-gal were performed on a luminometer (Glomax 20/20; Promega). Three independent experiments were performed in triplicate.
Western-blot
For western-blotting, proteins were extracted from tissues or cultured cells using RIPA buffer containing phenylmethanesulfonylfluoride(PMSF) (Beyotime, Nantong, China). Equal amount of proteins were separated with 12.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to polyvinylidene fluoride (PVDF) membrane. Primary polyclonal antibodies targeting IRF-1 (ab186384), Caspase3 (ab13847), PUMA (ab9643), and β-actin (ab3280) were purchased from Abcam 
Results

C>G SNP of rs56288038 in the 3′UTR region of IRF-1 was a risk factor in GC development
The characteristics of GC cases and controls are listed in Table 1 . No significant differences in age (P = 0.2690) and gender (P = 0.6516) were found between the case and the control group. There were more patients who had Hp infection in the cases than in the controls (P < 0.0001). All aforementioned variables were further adjusted for any residual confounding effect in the later multivariate logistic regression analysis.
To investigate the miR-NA-associated SNPs in the 3′UTR of IRF-1, we first found all possible SNPs in the 3′UTR of the IRF-1 gene with the minor allele frequency (MAF) > 0.05 from the SNP database ENSEM-BL v58. Then we used the bioinformatics software Diana-Micro and RNA hybrid to predict miRNAs that can bind to the IRF-1 3′UTR. Finally, we obtained three SNPs in the 3′UTR of IRF-1 which could be regulated by different miRNAs (Table 2). The positions of the SNPs in the 3′UTR of IRF-1, as well as other details including chromosome location, possible miRNA, and mutations, were also listed. Further genotyping was performed to detect the distribution of allele genes of the SNP in our research; rs56288038, which can be potentially regulated by miR-502-5p, followed a Hardy-Weinberg equilibrium distribution pattern in the healthy control group (P < 0.0001) (data not shown).
Logistic regression analyses indicated that individuals with the CG and GG genotypes of rs56288038 in the 3′UTR of IRF-1 were significantly associated with GC risk (P<0.0001).
Moreover, the significant association with GC risk was shown in G carrier of both SNPs (P < 0.0001) ( Table 3) Next we performed stratified analysis of the association of rs56288038 with the clinic-pathological parameters of GC (Table 4) . We found a significant association of both genotypes with Hp Infection, poor differentiation, bigger tumor size, metastasis, and depth of invasion (Table 4) .
rs56288038 can cause enhanced suppression of IRF-1 transcription by miR-502-5p
To investigate whether the rs56288038 SNPs affected the predicted miRNAs binding with IRF-1 3′UTR (Fig. 1A) we performed transient transfection in vitro and measured the relative activities with a Dual-Glo Luciferase Reporter Assay System. As it was indicated, co-transfection of the luciferase vector containing either wild-type and homozygous G mutant 3′UTR of IRF-1 plus miR-502-5p mimics and control into two GC cells, significantly decrease the luciferase expression level was found in the mutant compared to wild types (Fig. 1B) . SNP in the 3′UTR of IRF-1 can affect the binding affinity of miR-502-5p and then consequently affect the function of post-transcriptional regulation, resulting in abnormal expression levels of IRF-1. Furthermore, in order to confirm the expression of IRF-1 affected by SNP, we constructed and transfected wild-type (CC) and mutated (GG) 3′UTR IRF-1 during overexpression of IRF-1 plasmid into SGC-7901 cells; overexpression of IRF-1 was verified by using immunohistochemistry (IHC), and was relatively constant regardless of the expression of the genotype of 3′UTR. However, when miR-502-5p was transfected, the expression of IRF-1 decreased significantly, but IRF-1 was almost eliminated in SGC-7901 cells with GG IRF-1 3′UTR, which was similar to the result of luciferase reporter assay (Fig.  1C) . Furthermore, an IFN-γ (50 ng/mL)-induced apoptosis assay was performed. With the treatment of IFN-γ, increased apoptosis reflected by cleaved Caspase 3 was observed in IRF-1 overexpressed SGC-7901, but the apoptosis decreased dramatically when miR-502-5p was involved. However, the GG allele 3′UTR-transfected SGC-7901 was shown to be less sensitive to IFN-γ treatment due to decreased expression of IRF-1 and PUMA. (Fig. 1D) . We also confirmed the expression of IRF-1 in clinical samples with different genotypes of rs56288038. IRF-1 expression was detected in human GC by IHC. There was strong, medium, weak, and negative staining in varying sections. GG group IRF-1 staining components were significantly different to those in CG and CC groups in IRF-1 expression (strong 17.6%, medium 19.6%, weak 26.8%, and negative 36.0% for the CC group; strong 12.6%, medium 20.1%, weak 15.6%, and negative 51.7% for the CG group; and high 5.3%, medium 18.6%, weak 11.1%, and negative 65.0% for the GG group; P < 0.001) (Fig. 2A, B) . Real-time PCR further confirmed such differences in IRF-1 transcription. However, there was no significant difference in miR-502-5p expression between the three groups (Fig. 2C, D) .
C/G SNP in rs56288038 of the 3′UTR was associated with bad prognosis of post-surgery GC patients
Among a total of 819 GC patients, we have 406 patients with follow-up survival data. Survival rate analysis was performed in two groups. Firstly, the 5-year survival rate in the CG/GG group was lowest at 5.77%, significantly different from the CC group (HR: 2.315, 95% CI: 1.158-2.054, P < 0.0001) (Fig. 3A) . Moreover, the relapse-free survival rate was also analyzed and indicated similarly that CG/GG genotype has a worse prognosis than CC (HR: 2.207, 95% CI: 1.141-2.019, P < 0.0001). Our findings indicated that the C/G SNP might serve as a promoter factor in GC by affecting the binding of miR-502-5p on the 3′UTR of IRF-1. Data were presented as the mean ± SEM. * indicates P < 0.05 and ** indicates P < 0.01.
Discussion
IRF-1 was commonly regarded as a tumor suppressor and to be down-regulated in tumors, as reported by several studies. For instance, IRF-1 can induce apoptosis of gastric cancer by the intrinsic pathway independent of the extrinsic pathway by up-regulation of PUMA [14] . And overexpression of IRF-1 was regarded as a gene therapy method which can increase the chemotherapy sensitivity of gastric cancer cells [7] . Our data have revealed that SNP in the 3′UTR region of IRF-1 is a risk factor in human GC, and seriously associated with poor differentiation, tumor invasion depth, and metastasis of cancer; this association was also due to different expressions of IRF-1 in different sub-groups of GC with different genotype in the 3′UTR. IRF-1 has also been proved to be one of the transcriptional factors of IL-8 signaling, which regulates the mucosal inflammatory response to Hp infection [8] . In present study we also found that the SNP in the 3′UTR of IRF-1 was significantly associated with Hp Infection, and this research should help to explain differences in disease progress during Hp Infection.
SNP was a classical topic of research which indicated a variation in a single nucleotide that occurs at a specific position in the genome [15] . And with the development of research, especially the studies on miRNA, the SNPs in the 3′UTR region which were targets of miRNA have been shown in many studies to affect the binding of miRNA to cause "Gain" and "Loss" regulation of certain miRNAs [16, 17] . In our study, we found that the SNP can cause a "Gain" regulation of IRF-1 by miR-502-5p which has never been reported to be regulated. Although there is no obvious expression difference of miR-502-5p in human GC within different genotype groups, there is a significant difference in IRF-1 expression both in cell lines transfected with varying genotypes of 3′UTR of IRF-1 and in clinical samples. And the low expression of IRF-1 was associated with poor prognosis in post-surgery GC patients, which was also reported in other tumors such as HCC and ovarian cancer [18, 19] .
Generally, little information can be obtained about miR-502-5p. Several reports have addressed its function targeting varied genes such as TRAF2, SET-8, and TP53 in different diseases, including chondrocyte injury, breast cancer, and non-Hodgkin lymphoma [20] [21] [22] [23] [24] . Most of these studies implied that miR-502-5p was a tumor suppressor, indicating that miR-502-5p enhanced early apoptosis and inhibited proliferation of tumor cells by targeting TRAF2. No information was found concerning the roles of miR-502-5p in human GC. However, we discovered a new target of miR-502-5p, IRF-1, in cases of mutation occurred in its 3′UTR.
In the present study, we find that miR-502-5p has a potential transcriptional suppressive effect on IRF-1, and SNP in the 3′UTR region of IRF-1 can effectively be associated significantly with down-regulation of IRF-1, which might due to "Gain" regulation of miRNA. These findings are novel and might contribute to explain the individual differences in GC susceptibility. Wang 
